Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Window of Opportunity in Preserving Laryngeal Function (WOLF) Trial

NCT07423078 is registered in ClinicalTrials.gov with Matthew Spector as lead sponsor.

NCT NCT07423078
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07423078 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Window of Opportunity in Preserving Laryngeal Function (WOLF) Trial
Lead sponsor
Matthew Spector
Phase
Phase 2
Overall status
Recruiting
Start date
April 6, 2026
Completion date
April 30, 2031
Enrollment
87 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck squamous cell carcinoma (hnscc) - recurrent/metastatic (r/m), hypopharyngeal squamous cell carcinoma, locally advanced laryngeal squamous cell carcinoma